TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC

• Үндсэн зохиолчид: Yuntao Wang (Зохиогч), Yi Liu (Зохиогч), Xiaohua Li (Зохиогч), Weiming Li (Зохиогч), Zhihong Xue (Зохиогч), Xiaoqian He (Зохиогч), Weijie Xiong (Зохиогч), Lang He (Зохиогч), Yifeng Bai (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Background: Lung cancer has the highest morbidity and mortality rate among types of malignant tumors, and as such, research into prolonging the survival time of patients is vital. The emergence of immune checkpoint inhibitors (ICIs) has greatly improved the survival of patients with non-small cell l...